You are here
Nobivac® Myxo-RHD PLUS, lyophilisate and solvent for suspension for injection in rabbits
Nobivac Myxo-RHD PLUS is a live recombinant vector vaccine for rabbits indicated to reduce mortlity and clinical signs of myxomatosis and rabbit haemorrhagic disease (RHD) caused by both classic (RHDV-1) and variant strains (RHDV-2)
Presentation
Lyophilisate and solvent for suspension for injection
Lyophilisate: off-white or cream-coloured pellet
Solvent: clear colourless solution
Active ingredients
Each dose (0.2 ml or 0.5 ml) of reconstituted vaccine contains:
- Myxomatosis
- Classical RHD virus (RHDV-1)
- Variant RHD virus (RHDV-2)
Live myxoma vectored RHD virus strain 009: 103.0 - 105.8 FFU*
Live myxoma vectored RHD virus strain MK1899: 103.0 - 105.8 FFU*
*Focus Forming Units
Target species
Rabbits
Indications for use
For the active immunisation of rabbits from 5 weeks of age onwards to reduce mortality and clinical signs of myxomatosis and rabbit haemorrhagic disease (RHD) caused by classical RHD virus (RHDV-1) and RHD type 2 virus (RHDV-2).
Packaging
Plastic box with 5 x 1 dose vial of vaccine and 5 x 1 ml vial of solvent.
Legal category
POM-V
Learn more in the video below
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: March 2020
